For the National Health Council (NHC), 2021 was a year of transition. The NHC welcomed a new CEO, Randall Rutta, in February. Our new Strategic Plan was developed and adopted in December. The NHC managed the ever-changing environment during the second year of a global pandemic and a new Administration and Congress. Through it all, the NHC team rose to the challenge to deliver high-value resources, programming, and service to our members.
Made up of more than 145 national health- related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses representing biopharmaceutical, device, diagnostic, generic drug, and payer organizations.
The NHC maintained a long-standing member retention rate of over 90% in 2021 and added 11 new members in all 5 membership categories. New members included:
The NHC advanced the conversation around Health Equity by working with NHC membership and thought leaders outside of the NHC to develop policy recommendations for the four priority areas in the health equity consensus statement released late last year. The NHC also provided input and endorsed the DIVERSE Trials Act and created recommendations for the newly formed Congressional Caucus on Social Determinants of Health. We convened roundtable discussions on Equitable Access to Affordable and Comprehensive Health Insurance Coverage and an Inclusive, Equitable, Accessible, and High-Quality Care Delivery System. The NHC also hosted a virtual event on Inclusive Workplaces: Building A Representative Workforce.
In support of our members, the NHC hosted regular discussions on critical issues related to COVID-19 as part of our COVID-19 CEO and Senior Staff Webinar Series. Over the past 15 months, the NHC hosted 45 webinars with 76 different speakers. The topics ranged from the impact of COVID-19 on mental health; telemedicine; medical and drug supply shortages; and planning and hosting virtual events, meetings, and fly-ins. We also continued to advocate strongly for policy solutions to help the patient community during the COVID-19 pandemic, and wrapped up this year with a three-part series in partnership with Deloitte Consulting LLC – The Ultimate Change Agent: Coronavirus Pandemic.